These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 16136765)

  • 1. Safety of etoricoxib, a new cyclooxygenase 2 inhibitor, in patients with nonsteroidal anti-inflammatory drug-induced urticaria and angioedema.
    Sánchez-Borges M; Caballero-Fonseca F; Capriles-Hulett A
    Ann Allergy Asthma Immunol; 2005 Aug; 95(2):154-8. PubMed ID: 16136765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerability of three selective cyclo-oxygenase-2 inhibitors, meloxicam, celecoxib and rofecoxib in NSAID-sensitive patients.
    Senna G; Bilò MB; Antonicelli L; Schiappoli M; Crivellaro MA; Bonadonna P; Dama AR
    Eur Ann Allergy Clin Immunol; 2004 Jun; 36(6):215-8. PubMed ID: 15329003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerance of nonsteroidal anti-inflammatory drug-sensitive patients to the highly specific cyclooxygenase 2 inhibitors rofecoxib and valdecoxib.
    Sánchez-Borges M; Caballero-Fonseca F; Capriles-Hulett A
    Ann Allergy Asthma Immunol; 2005 Jan; 94(1):34-8. PubMed ID: 15702813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to a selective COX-2 inhibitor in patients with urticaria/angioedema induced by nonsteroidal anti-inflammatory drugs.
    Doña I; Blanca-López N; Jagemann LR; Torres MJ; Rondón C; Campo P; Gómez AI; Fernández J; Laguna JJ; Rosado A; Blanca M; Canto G
    Allergy; 2011 Nov; 66(11):1428-33. PubMed ID: 21834936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerance to etoricoxib in 37 patients with urticaria and angioedema induced by nonsteroidal anti-inflammatory drugs.
    Muratore L; Ventura M; Calogiuri G; Calcagnile F; Quarta E; Muratore M; Ferrannini A
    Ann Allergy Asthma Immunol; 2007 Feb; 98(2):168-71. PubMed ID: 17304885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of celecoxib in patients with adverse skin reactions to acetaminophen (paracetamol) and nimesulide associated or not with common non-steroidal anti-inflammatory drugs.
    Liccardi G; Salzillo A; Piccolo A; Senna G; Piscitelli E; D'Amato M; D'Amato G
    Eur Ann Allergy Clin Immunol; 2005 Feb; 37(2):50-3. PubMed ID: 15859361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerance to COX-2 inhibitors in children with hypersensitivity to nonsteroidal anti-inflammatory drugs.
    Corzo JL; Zambonino MA; Muñoz C; Mayorga C; Requena G; Urda A; Gallego C; Blanca M; Torres MJ
    Br J Dermatol; 2014 Mar; 170(3):725-9. PubMed ID: 24116718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NSAID-induced urticaria and angioedema: a reappraisal of its clinical management.
    Sánchez-Borges M; Capriles-Hulett A; Caballero-Fonseca F
    Am J Clin Dermatol; 2002; 3(9):599-607. PubMed ID: 12444802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urticaria and angioedema from cyclooxygenase-2 inhibitors.
    Kelkar PS; Butterfield JH; Teaford HG
    J Rheumatol; 2001 Nov; 28(11):2553-4. PubMed ID: 11708434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for acetaminophen and nimesulide intolerance in patients with NSAID-induced skin disorders.
    Asero R
    Ann Allergy Asthma Immunol; 1999 Jun; 82(6):554-8. PubMed ID: 10400483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term tolerability of etoricoxib in patients with cutaneous hypersensitivity reactions to nonsteroidal anti-inflammatory drugs.
    Nettis E; Colanardi MC; Ferrannini A; Vacca A; Tursi A
    Ann Allergy Asthma Immunol; 2005 Nov; 95(5):438-42. PubMed ID: 16312166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Approaches to the diagnosis and management of patients with a history of nonsteroidal anti-inflammatory drug-related urticaria and angioedema.
    Kowalski ML; Woessner K; Sanak M
    J Allergy Clin Immunol; 2015 Aug; 136(2):245-51. PubMed ID: 26254051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Provocation tests with the offending nonsteroidal anti-inflammatory drugs in patients with urticaria/angioedema reactions.
    Zisa G; Riccobono F; Bommarito L; D'Antonio C; Calamari AM; Poppa M; Moschella MA; Di Pietrantonj C; Galimberti M
    Allergy Asthma Proc; 2012; 33(5):421-6. PubMed ID: 23026184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are drug provocation tests still necessary to test the safety of COX-2 inhibitors in patients with cross-reactive NSAID hypersensitivity?
    Çelik GE; Erkekol FÖ; Aydın Ö; Demirel YS; Mısırlıgil Z
    Allergol Immunopathol (Madr); 2013; 41(3):181-8. PubMed ID: 23031659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of ketoprofen oral challenges to detect cross-reactors among patients with a history of aspirin-induced urticaria.
    Asero R
    Ann Allergy Asthma Immunol; 2006 Aug; 97(2):187-9. PubMed ID: 16937749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of celecoxib in patients with adverse skin reactions to acetaminophen (paracetamol) and other non-steroidal anti-inflammatory drugs.
    Liccardi G; Cazzola M; De Giglio C; Manfredi D; Piscitelli E; D'Amato M; D'Amato G
    J Investig Allergol Clin Immunol; 2005; 15(4):249-53. PubMed ID: 16433205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of etoricoxib in patients with reactions to NSAIDs.
    Quercia O; Emiliani F; Foschi FG; Stefanini GF
    J Investig Allergol Clin Immunol; 2008; 18(3):163-7. PubMed ID: 18564626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral drug challenges in non-steroidal anti-inflammatory drug-induced urticaria, angioedema and anaphylaxis.
    Chaudhry T; Hissaria P; Wiese M; Heddle R; Kette F; Smith WB
    Intern Med J; 2012 Jun; 42(6):665-71. PubMed ID: 21981353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of selective COX-2 inhibitors in aspirin/nonsteroidal anti-inflammatory drug-intolerant patients: comparison of nimesulide, meloxicam, and rofecoxib.
    Bavbek S; Celik G; Ozer F; Mungan D; Misirligil Z
    J Asthma; 2004 Feb; 41(1):67-75. PubMed ID: 15046380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of selective cyclooxygenase-2 inhibitors and a basic non-steroidal anti-inflammatory drug (NSAID) in Japanese patients with NSAID-induced urticaria and/or angioedema: Comparison of meloxicam, etodolac and tiaramide.
    Inomata N; Osuna H; Yamaguchi J; Onoda M; Takeshita Y; Chiba Y; Kambara T; Ikezawa Z
    J Dermatol; 2007 Mar; 34(3):172-7. PubMed ID: 17291297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.